Green Sands Equity

Green Sands Equity is a boutique private equity investment firm established in 2015 and located in San Francisco, California. The firm specializes in growth capital, investment advisory, and strategic buyouts, focusing on long-term investments in portfolio companies. Green Sands Equity primarily targets sectors such as space, technology, healthcare, and future technologies. Additionally, the firm offers expertise in political and policy strategy, facilitating connections between the private sector and government entities.

Bill Chua

Managing Director and Board Member

Sergio Fernandez de Cordova

Managing Director

Jenya Gusovsky

Venture Partner

Laurence Kalinsky

Managing Director

Reema Khan

Founder and CEO

Adrian Leuenberger

Managing Partner, Green Sands Switzerland

Shadi Sanbar

Managing Director and Board Member

Sajid Siddiqi

Managing Director

Davide Venturelli

Partner

32 past transactions

Axyon AI

Venture Round in 2025
Axyon AI SRL is a fintech company specializing in artificial intelligence-based software solutions for the banking and investment management sectors. Founded in 2016 and headquartered in Modena, Italy, with an office in London, Axyon AI develops advanced web applications that enhance decision-making for asset managers and corporate banks. Its flagship product, Axyon SynFinance, provides predictive analytics for liquidity, market conditions, and lead generation tailored for loan syndication desks. Another significant offering, Axyon IRIS, delivers periodic predictions on key financial metrics such as volatility and various performance ratios, aiding asset managers in strategy formulation. By leveraging deep learning technologies, Axyon AI creates customized predictive models that are designed to improve portfolio management and generate alpha, thereby facilitating innovative investment and risk management processes.

Stepful

Series B in 2024
Stepful is a training platform designed to help individuals without college degrees access entry-level healthcare jobs. Aimed at high school graduates, the platform offers a range of resources including online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to teach hands-on skills such as bloodwork. The company also offers job placement support to facilitate quick hiring and reduce costs for employers, thereby enabling its users to secure on-demand positions in the healthcare sector. Through its comprehensive training and support services, Stepful fosters career advancement opportunities for those seeking to grow within the medical field.

Axyon AI

Venture Round in 2024
Axyon AI SRL is a fintech company specializing in artificial intelligence-based software solutions for the banking and investment management sectors. Founded in 2016 and headquartered in Modena, Italy, with an office in London, Axyon AI develops advanced web applications that enhance decision-making for asset managers and corporate banks. Its flagship product, Axyon SynFinance, provides predictive analytics for liquidity, market conditions, and lead generation tailored for loan syndication desks. Another significant offering, Axyon IRIS, delivers periodic predictions on key financial metrics such as volatility and various performance ratios, aiding asset managers in strategy formulation. By leveraging deep learning technologies, Axyon AI creates customized predictive models that are designed to improve portfolio management and generate alpha, thereby facilitating innovative investment and risk management processes.

TreQ

Seed Round in 2024
TreQ is a manufacturing company specializing in the production of bespoke quantum computing clusters. These clusters are designed to tackle complex computational problems that are currently beyond the capabilities of classical computers. By leveraging quantum mechanics, TreQ's systems can perform a single calculation that would be impractical or impossible for traditional computers, thereby enabling businesses and institutions to optimize asset allocation, minimize risk, and make data-driven decisions more effectively.

Ephos

Seed Round in 2024
Ephos specializes in manufacturing high-performance integrated photonic circuits using proprietary glass technology. Its products minimize signal loss, facilitating innovative designs for classical and quantum computing applications, as well as quantum communications and sensing. Ephos caters to the computational infrastructure sector, offering tailored, high-quality solutions.

Vectara

Series A in 2024
Vectara is a developer of a generative AI product platform that enables businesses to integrate advanced AI features into their applications. The company offers an end-to-end serverless Retrieval Augmented Generation (RAG) API platform, which provides a secure and efficient way to incorporate conversational AI and question-answering capabilities. Vectara's platform is built on a hybrid-search core, ensuring accurate and reliable results that are grounded in the specific data and knowledge of the organization. It addresses critical challenges associated with enterprise adoption, such as reducing hallucination, enhancing explainability, enforcing access control, and allowing for real-time updates of knowledge. Additionally, Vectara's platform supports multilingual capabilities and prioritizes data security, making it suitable for various applications including semantic search, research analysis, and conversational AI, thus enabling organizations to create experiences similar to ChatGPT.

Elve

Series A in 2024
Elve is a manufacturer specializing in high-efficiency, lightweight millimeter wave and near-terahertz power amplifiers designed to enhance wireless connectivity. The company focuses on developing advanced technologies that facilitate fiber-like wireless internet links, thereby improving the overall online experience for users. By integrating agile manufacturing techniques into their vacuum electronic devices, Elve aims to provide innovative solutions that support widespread connectivity in various applications.

Stepful

Series A in 2024
Stepful is a training platform designed to help individuals without college degrees access entry-level healthcare jobs. Aimed at high school graduates, the platform offers a range of resources including online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to teach hands-on skills such as bloodwork. The company also offers job placement support to facilitate quick hiring and reduce costs for employers, thereby enabling its users to secure on-demand positions in the healthcare sector. Through its comprehensive training and support services, Stepful fosters career advancement opportunities for those seeking to grow within the medical field.

Fizz

Series B in 2023
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

Sagence AI

Series A in 2023
Analog Inference is a company focused on advancing neural computing through innovative technology. Founded by experienced professionals from the computing industry and supported by Khosla Ventures, the company is developing its first generation of products. It specializes in deep sub-threshold analog in-memory computation, which allows for the execution of complex neural networks at full resolution while maintaining low latency and eliminating the need for active cooling. This technology enables the performance of data-center-grade artificial intelligence workloads with significantly reduced power consumption, facilitating the deployment of server-class networks in more cost-effective devices.

Paradromics

Series A in 2023
Paradromics, Inc. is a company focused on developing advanced brain-machine interfaces aimed at transmitting data between the brain and external devices. Founded in 2015 and based in Austin, Texas, Paradromics manufactures implantable systems that facilitate neural data decoding, converting intricate neural recordings into data streams suitable for various neural prostheses. The company's technology is designed to enhance data transmission rates, providing high-volume, bidirectional data streaming capabilities. This innovation aims to assist individuals with neurodegenerative diseases and other neurological conditions by compensating for the loss of biological connectivity. In addition to its core products, Paradromics also develops applications to support its technology solutions.

PASQAL

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Elve

Venture Round in 2023
Elve is a manufacturer specializing in high-efficiency, lightweight millimeter wave and near-terahertz power amplifiers designed to enhance wireless connectivity. The company focuses on developing advanced technologies that facilitate fiber-like wireless internet links, thereby improving the overall online experience for users. By integrating agile manufacturing techniques into their vacuum electronic devices, Elve aims to provide innovative solutions that support widespread connectivity in various applications.

ArsenalBio

Series B in 2022
ArsenalBio is a programmable cell therapy company established in 2019, focused on developing and commercializing innovative immune cell therapies, particularly for cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create multifunctional T-cell therapies. ArsenalBio's approach involves the precise insertion of large synthetic DNA sequences, enabling the generation of next-generation autologous T-cell therapies. By integrating these cutting-edge methods, ArsenalBio aims to enhance the effectiveness and safety of immune cell therapies, reduce costs for healthcare providers, and improve market access, ultimately broadening patient outcomes and making these therapies more widely available.

Qenta

Venture Round in 2022
Qenta is a financial technology platform established in 2016 and headquartered in Houston, Texas. The company specializes in cashless payment processing, primarily serving the Austrian and Central European markets. Qenta offers a comprehensive suite of financial services designed for enterprises, financial institutions, and individual users. Its platform integrates advanced solutions that include asset tokenization and innovative blockchain technologies. Additionally, Qenta provides guidance on both offline and online payment methods, addressing security requirements and facilitating risk-free online transactions. By tailoring international payment strategies to specific sales channels, Qenta aims to enhance the payment experience for its diverse clientele.

Stepful

Venture Round in 2022
Stepful is a training platform designed to help individuals without college degrees access entry-level healthcare jobs. Aimed at high school graduates, the platform offers a range of resources including online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to teach hands-on skills such as bloodwork. The company also offers job placement support to facilitate quick hiring and reduce costs for employers, thereby enabling its users to secure on-demand positions in the healthcare sector. Through its comprehensive training and support services, Stepful fosters career advancement opportunities for those seeking to grow within the medical field.

Good Chemistry

Seed Round in 2022
Good Chemistry Company is focused on enhancing health, sustainability, and environmental quality through advanced material design. The company has developed QEMIST Cloud, a cloud-based computational chemistry platform that enables developers to create chemical simulation applications and workflows. By leveraging cutting-edge algorithms in quantum chemistry, machine learning, and quantum computing, Good Chemistry provides tools that allow for the rapid and accurate prediction of chemical properties, significantly accelerating the material design process.

Colossal Laboratories & Biosciences

Series A in 2022
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

Devoted

Series D in 2021
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.

USA Rare Earth

Venture Round in 2021
USA Rare Earth LLC is a mineral processing and exploration company based in New York, founded in 2019. It operates the Round Top Heavy Rare Earth, Lithium, and Critical Minerals Project, in which it holds an 80% interest. The Round Top project is notable for its diverse array of critical heavy rare earth elements and high-tech metals, including lithium, gallium, uranium, and beryllium. According to a Preliminary Economic Assessment, Round Top is expected to become one of the lowest-cost producers of rare earth elements and lithium globally. By supplying essential materials, USA Rare Earth aims to support the United States' defense and consumer electronics industries, thereby contributing to advancements in energy, mobility, and national security.

Commure

Series D in 2021
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.

Noble Money

Seed Round in 2021
Noble Money is a digital currency company focused on broadening the accessibility of sound money for individuals worldwide. The company aims to facilitate the adoption of digital currencies, starting with governmental integration. It specializes in the tokenization of digital currencies, working to enhance their usability and acceptance in various sectors. Through its initiatives, Noble Money aspires to make digital currencies a viable option for everyday transactions, ultimately promoting financial inclusivity and innovation in the monetary landscape.

Senti Bio

Series B in 2021
Senti Bio, established in 2016 and headquartered in South San Francisco, specializes in synthetic biotechnology for therapeutic development. The company's core focus is engineering gene circuits, a platform technology that enables precise control over cellular behavior. Senti Bio's innovative approach allows for the creation of therapies with enhanced specificity and control, particularly in oncology. Their product pipeline includes SENTI-202, a targeted cancer therapy using gene-engineered allogeneic CAR-NK cells designed to eliminate cancer cells while sparing healthy bone marrow, and SENTI-301A for treating hepatocellular carcinoma.

AST SpaceMobile

Venture Round in 2021
AST SpaceMobile is a satellite designer and manufacturer headquartered in Midland, Texas, focused on creating the first global broadband cellular network in space. Founded in 2017, the company aims to provide direct connectivity to standard, unmodified mobile devices, addressing the connectivity gaps faced by billions of mobile subscribers worldwide. By leveraging its extensive intellectual property and patent portfolio, AST SpaceMobile is developing a service that offers cost-effective, high-speed cellular broadband to users in areas lacking terrestrial cellular coverage. The company's mission is to connect the unconnected by enabling reliable mobile communication for those who currently lack access to broadband services.

ReViral

Series C in 2020
ReViral Ltd is a biotechnology company based in Stevenage, United Kingdom, specializing in the discovery and development of antiviral drugs targeting respiratory syncytial virus (RSV). Founded in 2011, ReViral is focused on creating innovative first-in-class compounds, including a highly potent fusion inhibitor designed specifically for treating severe RSV infections, particularly in vulnerable populations such as neonates. By advancing these novel antiviral treatments, ReViral aims to address significant unmet medical needs and expand the antiviral market, ultimately improving patient outcomes for those affected by RSV.

Praxis Precision Medicines

Series C in 2020
Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders marked by neuronal imbalance. Established in 2015 and headquartered in Cambridge, Massachusetts, the company leverages genetic insights to create innovative treatments for neurological and psychiatric conditions. Its leading product candidates include PRAX-114, an allosteric modulator targeting GABAA receptors, currently undergoing Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, along with PRAX-222, an antisense oligonucleotide aimed at treating patients with SCN2A epilepsy, and a program focused on KCNT1-related epilepsy. The company has established collaborations and licensing agreements with various organizations to enhance its research and development efforts.

Encoded Therapeutics

Series D in 2020
Encoded Therapeutics, Inc. is a biotechnology company focused on developing precision gene therapies for severe genetic disorders. Utilizing its proprietary platform, the company identifies genomic sequences that regulate gene expression, facilitating advancements in viral gene therapy. Encoded Therapeutics has a diverse therapy pipeline targeting various genetic and acquired disorders across multiple disease pathways, including neurocircuitry, metabolic disorders, neurodegeneration, and cardiovascular diseases. Founded in 2014 and headquartered in South San Francisco, California, the company is dedicated to improving patient outcomes through innovative gene therapy solutions.

Didi

Venture Round in 2020
Didi Chuxing, founded in 2012 in Beijing, is a leading mobile transportation platform providing app-based services such as taxi hailing, private car-hailing, social ride-sharing, car rental, and enterprise solutions. With over 450 million users and daily orders reaching 25 million, Didi offers a variety of mobility options to optimize resource allocation through big data-driven algorithms. The company aims to address transportation, environmental, and employment challenges by collaborating with communities and partners. Acquiring Uber China in 2016, Didi has over 21 million drivers and car owners on its platform, generating income while offering convenient transportation solutions to users worldwide.

BedRock Systems

Venture Round in 2020
Our Mission is to BedRock the world’s critical systems from Edge to Server and Cloud implementing the most trusted Provably Unbreakable™ and Programmable Hypervisor platform with Active Security™

Whiterabbit.ai

Venture Round in 2020
Whiterabbit.ai specializes in creating artificial intelligence-driven software designed to enhance the early detection and diagnosis of breast cancer. The company's platform aims to transform the cancer screening process by addressing key challenges, including patient compliance and provider accuracy. By leveraging advanced technology, Whiterabbit.ai seeks to improve patient engagement and overall care quality, ultimately enhancing outcomes in cancer diagnosis and treatment.

1QBit

Series B in 2017
1QBit is a quantum computing software company focused on addressing complex computational challenges. By recasting problems to leverage the capabilities of quantum computing, the company develops innovative solutions that are designed to solve intractable issues across various industries. Its software platform integrates machine intelligence and optimization science, providing a hardware-agnostic approach that allows clients and hardware providers to enhance applications with advancements in both classical and quantum computing technologies. Through its work, 1QBit aims to enable the development of novel approaches that can significantly improve computational efficiency and effectiveness.

Lyft

Venture Round in 2017
Lyft is a transportation company that operates a mobile application connecting passengers with drivers for on-demand rides. The app facilitates ride scheduling, including advance bookings up to seven days, and handles in-app payments. Primarily serving college, university, and corporate communities, Lyft offers various ride options, such as private, shared, and luxury vehicles. Additionally, it provides multimodal transportation solutions, including bike and scooter sharing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.